Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran - A prospective multicenter point prevalence study

Journal of Infection

Volumn 68, Issue 2, 2014, Pages 131-140

  Erdem, Hakan ^a   Inan, Asuman ^a   Altindis, Selma ^b   Carevic, Biljana ^c   Askarian, Mehrdad ^d   Cottle, Lucy ^e   Beovic, Bojana ^f   Csomos, Akos ^g   Metodiev, Krassimir ^h   Ahmetagic, Sead ⁱ   Harxhi, Arjan ^j   Raka, Lul ^k   Grozdanovski, Krsto ^l   Nechifor, Mihai ^m   Alp, Emine ⁿ   Bozkurt, Fatma ^o   Hosoglu, Salih ^o   Balik, Ismail ^p   Yilmaz, Gulden ^p   Jereb, Matjaz ^f   Moradi, Fatemeh ^q   Petrov, Nikolay ^r   Kaya, Selcuk ^s   Koksal, Iftihar ^s   Aslan, Turan ^t   Elaldi, Nazif ^u   Akkoyunlu, Yasemin ^t   Moravveji, Seyyed Alireza ^v   Csato, Gabor ^w   Szedlak, Balazs ^x   Akata, Filiz ^y   Oncu, Serkan ^z   Grgic, Svjetlana ^aa   Cosic, Gorana ^ab   Stefanov, Chavdar ^ac   Farrokhnia, Mehrdad ^ad   Müller, Mária ^ae   Luca, Catalina ^m   Koluder, Nada ^af   Korten, Volkan ^ag   Platikanov, Viliyan ^ah   Ivanova, Petja ^ah   Soltanipour, Soheil ^ai   Vakili, Mahmood ^aj   Farahangiz, Saman ^d   Afkhamzadeh, Abdorrahim ^ak   Beeching, Nicholas ^e   Ahmed, Salman Shaheer ⁿ   Cami, Alma ^j   Shiraly, Ramin ^al   Jazbec, Anja ^f   Mirkovic, Tomislav ^f   Leblebicioglu, Hakan ^am   Naber, Kurt ^an   more..

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b SAKARYA UNIVERSITY   (Turkey)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^f UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

ⁱ University Clinical Center Tuzla   (Bosnia and Herzegovina)

^j UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^k UNIVERSITY OF PRISHTINA   (Serbia)

^l Department of Intensive Care   (Macedonia)

^m GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

ⁿ ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^o DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^p ANKARA UNIVERSITY   (Turkey)

^q Clinical Research Center on Infectious Diseases and Tropical Medicine   (Iran)

^r MILITARY MEDICAL ACADEMY   (Bulgaria)

^s KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^t Bezmi Alem University School of Medicine   (Turkey)

^u CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^v KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^w Kenezy Hospital Ltd   (Hungary)

^x Borsod County Teaching Hospital   (Hungary)

^y TRAKYA UNIVERSITY   (Turkey)

^z ADNAN MENDERES UNIVERSITY   (Turkey)

^aa University Hospital Clinic for Infectious Diseases   (Bosnia and Herzegovina)

^ab UNIVERSITY OF NOVI SAD   (Serbia)

^ac Clinic of Dermatology and Venerology   (Bulgaria)

^ad KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ae Markhot Ferenc Hospital   (Hungary)

^af Clinic for Infectious Diseases   (Bosnia and Herzegovina)

^ag MARMARA UNIVERSITY   (Turkey)

^ah UNIVERSITY HOSPITAL ST MARINA   (Bulgaria)

^ai GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^aj SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ak KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^al ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^am ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^an TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

Europe; ICU; Infection; Iran; Resistance; Turkey

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; DAPTOMYCIN; LINEZOLID; METRONIDAZOLE; ORNIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; COMMUNITY ACQUIRED INFECTION; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEVICE INFECTION; DISEASE SEVERITY; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; IRAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PREVALENCE; PRIMARY INFECTION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; SOUTHERN EUROPE; TREATMENT DURATION; TURKEY (REPUBLIC);

EUROPE; ICU; INFECTION; IRAN; RESISTANCE; TURKEY;

ADULT; AGED; COMMUNICABLE DISEASES; CROSS INFECTION; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HUMANS; INTENSIVE CARE UNITS; IRAN; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; TURKEY;

EID: 84892433674     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.11.001     Document Type: Article

References (24)

1. Erdem H., Akova M. Leading infectious diseases problems in Turkey. Clin Microbiol Infect 2012, 18(11):1056-1067.
2. Shibl A., Senok A., Memish Z. Infectious diseases in the Arabian Peninsula and Egypt. Clin Microbiol Infect 2012, 18(11):1068-1080.
3. Askarian M., Mansour Ghanaie R., Karimi A., Habibzadeh F. Infectious diseases in Iran: a bird's eye view. Clin Microbiol Infect 2012, 18(11):1081-1088.
4. Bonten M.J. Healthcare epidemiology: ventilator-associated pneumonia: preventing the inevitable. Clin Infect Dis 2011, 52(1):115-121.
5. Allegranzi B., Bagheri Nejad S., Combescure C., Graafmans W., Attar H., Donaldson L., et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011, 377(9761):228-241.
6. Erdem H., Dizbay M., Karabey S., Kaya S., Demirdal T., Koksal I., et al. Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control 2013, 41(11):1053-1058.
7. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31(4):1250-1256.
8. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18(3):268-281.
9. Freeman G.H., Halton J.H. Note on exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951, 38:141-149.
10. Firth P., Ttendo S. Intensive care in low-income countries - a critical need. N Engl J Med 2012, 367(21):1974-1976.
11. Erdem H., Kurtaran B., Arun O., Yilmaz H., Celebi G., Ozkaya H.D., et al. The place and the efficacy of infectious disease consultations in the hospitals. Infect Dis Clin Pract 2012, 20:131-136.
12. McGahan M., Kucharski G., Coyer F. Nurse staffing levels and the incidence of mortality and morbidity in the adult intensive care unit: a literature review. Aust Crit Care 2012, 25(2):64-77.
13. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. J Am Med Assoc 1995, 274(8):639-644.
14. Vincent J.L., Rello J., Marshall J., Silva E., Anzueto A., Martin C.D., et al. International study of the prevalence and outcomes of infection in intensive care units. J Am Med Assoc 2009, 302(21):2323-2329.
15. Pilato F., Profice P., Dileone M., Ranieri F., Capone F., Minicuci G., et al. Stroke in critically ill patients. Minerva Anestesiol 2009, 75(5):245-250.
16. Rubenfeld G.D. Interventions to improve long-term outcomes after critical illness. Curr Opin Crit Care 2007, 13(5):476-481.
17. Vardakas K.Z., Rafailidis P.I., Konstantelias A.A., Falagas M.E. Predictors of mortality in patients with infections due to multidrug resistant Gram negative bacteria: the study, the patient, the bug or the drug?. J Infect 2013, 66(5):401-414.
18. Rosenthal V.D., Maki D.G., Salomao R., Moreno C.A., Mehta Y., Higuera F., et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006, 145(8):582-591.
19. Mehta Y., Jaggi N., Rosenthal V.D., Rodrigues C., Todi S.K., Saini N., et al. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 21 adult intensive-care units from 10 cities in India: findings of the International Nosocomial Infection Control Consortium (INICC). Epidemiol Infect 2013, 1-9.
20. Bukhari S.Z., Hussain W.M., Banjar A.A., Fatani M.I., Karima T.M., Ashshi A.M. Application of ventilator care bundle and its impact on ventilator associated pneumonia incidence rate in the adult intensive care unit. Saudi Med J 2012, 33(3):278-283.
21. Schwaber M.J., Carmeli Y. The effect of antimicrobial resistance on patient outcomes: importance of proper evaluation of appropriate therapy. Crit Care 2009, 13(1):106.
22. Giske C.G., Monnet D.L., Cars O., Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrobial Agents Chemother 2008, 52(3):813-821.
23. Inan A., Ozgultekin A., Akcay S.S., Engin D.O., Turan G., Ceran N., et al. Alterations in bacterial spectrum and increasing resistance rates in isolated microorganisms from device-associated infections in an intensive care unit of a teaching hospital in Istanbul (2004-2010). Jpn J Infect Dis 2012, 65(2):146-151.
24. Pourakbari B., Sadr A., Ashtiani M.T., Mamishi S., Dehghani M., Mahmoudi S., et al. Five-year evaluation of the antimicrobial susceptibility patterns of bacteria causing bloodstream infections in Iran. J Infect Dev Ctries 2012, 6(2):120-125.